Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production

Antibodies are key immune effectors that confer protection against pathogenic threats. The nature and longevity of the antibody response to SARS-CoV-2 infection are not well defined. We charted longitudinal antibody responses to SARS-CoV-2 in 92 subjects after symptomatic COVID-19. Antibody response...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuezhou, Zuiani, Adam, Fischinger, Stephanie, Mullur, Jyotsna, Atyeo, Caroline, Travers, Meghan, Lelis, Felipe J.N., Pullen, Krista M., Martin, Hannah, Tong, Pei, Gautam, Avneesh, Habibi, Shaghayegh, Bensko, Jillian, Gakpo, Deborah, Feldman, Jared, Hauser, Blake M., Caradonna, Timothy M., Cai, Yongfei, Burke, John S., Lin, Junrui, Lederer, James A., Lam, Evan Christopher, Lavine, Christy L., Seaman, Michael S., Chen, Bing, Schmidt, Aaron G., Balazs, Alejandro Benjamin, Lauffenburger, Douglas A., Alter, Galit, Wesemann, Duane R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608032/
https://www.ncbi.nlm.nih.gov/pubmed/33171099
http://dx.doi.org/10.1016/j.cell.2020.10.051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608032/
https://www.ncbi.nlm.nih.gov/pubmed/33171099
http://dx.doi.org/10.1016/j.cell.2020.10.051

Ejemplares similares